ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CNTG Centogene NV

0.4406
0.0066 (1.52%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Centogene NV CNTG NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0066 1.52% 0.4406 14:00:02
Open Price Low Price High Price Close Price Previous Close
0.438 0.43 0.4557 0.442851 0.434
more quote information »

Recent News

Date Time Source Heading
03/4/202407:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notice
19/3/202421:30GLOBECENTOGENE Extends Strategic Partnership With Takeda to..
01/3/202409:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202409:00GLOBECENTOGENE Collaborates on Research Published in Science..
28/2/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/2/202422:30GLOBECENTOGENE Announces Receipt of Nasdaq Notice of Delisting..
28/2/202422:30GLOBECENTOGENE Explores Strategic Alternatives
28/2/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/1/202422:30GLOBECENTOGENE and the Laboratory of Human Genetics of Infectious..
25/1/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202422:30GLOBECENTOGENE Receives French Research Tax Credit Accreditation
24/1/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202422:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202422:30GLOBECENTOGENE and The Michael J. Fox Foundation Announce..
18/1/202423:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/1/202422:30GLOBECENTOGENE Announces Preliminary Full Year 2023 Revenue
19/12/202323:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202322:30GLOBECENTOGENE Announces Voting Results of Extraordinary General..
18/12/202322:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202322:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202322:30GLOBECENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study,..
01/12/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202322:30GLOBECENTOGENE and Lifera, a Public Investment Fund (PIF)..
28/11/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202300:30GLOBECENTOGENE, University College London, and Global Team of..
04/11/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/10/202322:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202321:30GLOBECENTOGENE Expands Multiomic Diagnostic Portfolio With..
07/10/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202322:30GLOBECENTOGENE to Present at H.C. Wainwright 25th Annual Global..
08/9/202307:00GLOBECENTOGENE Reports First Half 2023 Financial Results
08/9/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202322:00GLOBECENTOGENE Announces Publication Establishing Lyso-Gb1 as a..
01/9/202306:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notification..
01/9/202306:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/8/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/8/202320:30GLOBECENTOGENE to Participate in Upcoming Conferences in August
14/7/202320:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/7/202320:30GLOBECENTOGENE Regains Compliance With Nasdaq Listing..
12/7/202321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202321:30GLOBECENTOGENE Biodatabank Reveals Unique Genetic Variants in..
02/7/202319:00PRNUSLifera and CENTOGENE, Enter Strategic Collaboration -..
01/7/202306:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/7/202306:30GLOBECENTOGENE Announces Approval of All Resolutions Tabled at..
27/6/202321:30GLOBECENTOGENE and Lifera, a Biopharma Company Owned by the PIF,..
15/6/202306:30GLOBECENTOGENE Receives Nasdaq Notification Regarding Minimum..
17/5/202308:25GLOBECENTOGENE Reports Full Year 2022 Financial Results

Your Recent History

Delayed Upgrade Clock